Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
Doctors explain what types of conditions the term includes—and whether they're preventable.
New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...
Since expenditures are heavily skewed, the top 5 percent of patients by cost contribute a disproportionate amount to the mean ...
Arkansas research institutions stand to lose millions in research funding due to cuts planned by the administration of ...
The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...
Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...
A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...
The famed cherry blossoms on the University of Washington campus in Seattle. (GeekWire File Photo / Kurt Schlosser) The fight ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results